as 06-25-2025 4:00pm EST
AirSculpt Technologies Inc is a national provider of body contouring procedures delivering a premium consumer experience under its brand Elite Body Sculpture. Elite Body Sculpture, provides custom body contouring using the proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure. The company has one operating and reportable segment, direct medical procedure services.
Founded: | 2012 | Country: | United States |
Employees: | N/A | City: | MIAMI BEACH |
Market Cap: | 166.3M | IPO Year: | 2021 |
Target Price: | $3.75 | AVG Volume (30 days): | 698.1K |
Analyst Decision: | Hold | Number of Analysts: | 3 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.30 | EPS Growth: | N/A |
52 Week Low/High: | $1.53 - $9.20 | Next Earning Date: | 08-08-2025 |
Revenue: | $172,101,000 | Revenue Growth: | -12.96% |
Revenue Growth (this year): | -7.81% | Revenue Growth (next year): | 4.90% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Feinstein Adam T | AIRS | Director10% Owner | Jun 9 '25 | Buy | $4.00 | 1,000,000 | $4,000,000.00 | 14,038,819 | |
Rollins Aaron | AIRS | Executive Chairman | May 19 '25 | Buy | $3.60 | 2,118 | $7,629.04 | 15,146,039 | |
Jashnani Yogesh | AIRS | Chief Executive Officer | May 7 '25 | Buy | $2.65 | 7,000 | $18,532.50 | 464,879 |
AIRS Breaking Stock News: Dive into AIRS Ticker-Specific Updates for Smart Investing
GlobeNewswire
10 days ago
Simply Wall St.
12 days ago
MT Newswires
14 days ago
GlobeNewswire
14 days ago
MT Newswires
15 days ago
GlobeNewswire
16 days ago
MT Newswires
16 days ago
GlobeNewswire
16 days ago
The information presented on this page, "AIRS AirSculpt Technologies Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.